Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RTX vs MRNA✓SelectedUSD · MRNARTX vs MRNA performance historyLatest closeAs of+1.60%11/17
Stock and ETF performance explorer

RTX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+214.1%
MRNA return
+840.0%
Excess return
-625.9%
Maximum drawdown
-52.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.6%-3.9%+5.5%+1.6%
7D-1.1%-17.6%+16.4%-1.0%
30D+2.1%-5.1%+7.2%+2.1%
3M-10.7%+220.8%-231.5%-12.0%
6M+16.5%+321.7%-305.2%+14.1%
YTD+9.1%+601.3%-592.1%+5.7%
1Y+14.4%+735.2%-720.8%+10.4%
3Y+161.9%+170.5%-8.7%+155.5%
5Y+152.1%-14.6%+166.7%+145.0%
All+214.1%+840.0%-625.9%+215.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling